Navigation Links
A Protein May Help In Weight Loss Treatment

Researchers claim to have discovered a process by which a small protein acts directly within muscles to increase the body's metabolism to burn fat while simultaneously suppressing appetite. // This discovery could potentially become a promising new weight loss treatment.

The new study by a team led by a Canadian researcher, Dr. Greg Steinberg reveals how a small protein acts directly within muscles to increase the body's metabolism to burn fat while at the same time suppressing appetite. The protein is knows as the ciliary neurotrophic factor (CNTF). The Heart and Stroke Foundation of Canada, the Canadian Institutes of Health Research, and the Canadian Diabetes Association are funding the research.

They believe that the protein activates an enzyme, skeletal muscle AMP kinase, which increases the ability of the body to metabolise fat and sugar. This study they hope may lead to new strategies to reduce the risk of metabolic abnormalities associated with excess weight.

Steinberg's research shows how CNTF activates similar pathways to those stimulated by exercise. He said that earlier most obesity research has focused on the regulation of appetite by hormones such as leptin. But it is now found that leptin is ineffective in obesity due to the presence of proteins which inhibit their ability to stimulate fat metabolism, he said. He explained that fortunately, CNTF's effects on fat burning are being maintained.

Dr. Diane Finegood, scientific director of the Canadian Institutes of Health Research Institute of Nutrition, stated, this research is an important step for unravelling the complex biological systems controlling body weight, including mechanisms regulating blood sugar levels, food intake, and satiety meaning the feeling of fullness which are crucial to tackling the worldwide epidemic of obesity.

Researchers are working on the pill. But health experts feel it's still a long shot. Actually though Dr.Steinberg is not the first to come to this conclusion, an American pharmaceutical company Regeneron already owns the rights to recombinant CNTF and had completed phase 3 clinical trials of its CNTF medication Axokine. But the trails were discontinued when patients developed antibodies to CNTF that neutralized the effect of the drug.


'"/>




Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Evidence Links Protein Damage to Neurodegenerative diseases like Parkinsons and Alzheimers
3. Unravelling the secrets of ‘Huntingtin’ Protein - towards the treatment of ‘Huntingtons’ Disase
4. Unravelling the secrets of ‘Huntingtin’ Protein - towards the treatment of Huntingtins’ Disese
5. Protein in urine foresees heart disease
6. Levels Of Blood Proteins May Help Heart Disease Care
7. Protein signals need for heart surgery
8. Protein and fat improve memory
9. Clotting Protein plays a role in nerve repair
10. High Levels of Protein Linked to Brain Shrinkage
11. Protein can change worn muscle fibres
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2016)... CA (PRWEB) , ... February 08, 2016 , ... The ... held annually in this country. The AutismOne 2016 Conference, which is being held May ... they often won’t hear elsewhere about helpful interventions and causes of chronic illness in ...
(Date:2/7/2016)... Scottsdale, AZ (PRWEB) , ... February 07, 2016 ... ... & Neck and Facial Plastics, has added Kybella® to his medical and surgical ... is a newly approved FDA injectable medication used as a non-surgical alternative for ...
(Date:2/6/2016)... ... February 06, 2016 , ... Research ... treatment helps to reduce the frequency and level of relapse. , ... Healthy Identity and Purpose,” will explore the critical tasks of the recovery phase ...
(Date:2/5/2016)... ... 2016 , ... Successful recruitment and retention efforts, new collaborations ... have all marked the last 12 months at Roswell Park Cancer Institute (RPCI). ... oldest cancer center, Candace S. Johnson, PhD, outlined the many accomplishments of her ...
(Date:2/5/2016)... ... February 05, 2016 , ... Freed-Hardeman University President Joe A. ... a joint enrollment and degree completion agreement. The agreement, which begins with ... at FHU|Dickson. , The agreement allows students to be jointly admitted to ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... Site Profile: --> ... The Speech Recognition People, announced their latest primary healthcare case study ... reduce turnaround times and to save the practice money. ... 2013 Challenge: --> ,- Wirral CCG ,- ... Six doctors ,- Wirral CCG ,- VoicePower client since 2013 ...
(Date:2/4/2016)...  The Senior Care Pharmacy Coalition (SCPC) today ... Jason Chaffetz (R-UT) and Ranking Member ... , "Developments in the Prescription Drug Market," to ... about abusive pharmacy benefit manager (PBM) pricing practices. ... Member Elijah Cummings (D-MD) are diligent, serious lawmakers ...
(Date:2/4/2016)... , Feb. 4, 2016  Montoya Love is ... in the field of Pharmaceuticals. Montoya is the Regulatory ... Manufacturing and ... Becton Dickinson provides healthcare institutions, clinical laboratories ... throughout fifty countries across the globe. ...
Breaking Medicine Technology: